<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR21">
 <label>21.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Moreau</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study</article-title>
  <source>Lancet Oncol.</source>
  <year>2011</year>
  <volume>12</volume>
  <fpage>431</fpage>
  <lpage>440</lpage>
  <pub-id pub-id-type="doi">10.1016/S1470-2045(11)70081-X</pub-id>
  <?supplied-pmid 21507715?>
  <pub-id pub-id-type="pmid">21507715</pub-id>
 </element-citation>
</ref>
